Pharmaceutical developer ImaRx Therapeutics has appointed Bradford Zakes as vice president, business development.
Zakes, formerly a director of business management at pharmaceutical firm Icos, will be responsible for setting strategic business direction and driving licensing, co-development, and marketing activities for the Tucson, AZ-based firm's NanoInvasive products and technologies.
By AuntMinnie.com staff writers
September 8, 2005
Related Reading
ImaRx receives $1.1 million grant, August 2, 2005
ImaRx's SonoLysis begins phase I/II PAOD trial, April 12, 2005
ImaRx initiates SonoLysis phase II stroke trial, April 5, 2005
ImaRx raises $7 million, March 10, 2005
ImaRx, Guerbet in MR molecular imaging deal, December 10, 2004
Copyright © 2005 AuntMinnie.com
